CYTOCHALASIN B

CYTOCHALASIN B is a lipid of Polyketides (PK) class. Cytochalasin b is associated with abnormalities such as Renal tubular disorder and Chagas Disease. The involved functions are known as Membrane Protein Traffic, inhibitors, Metabolic Inhibition, Biochemical Pathway and Increased Sensitivy. Cytochalasin b often locates in Cytoplasmic matrix, Plasma membrane, Microtubules, Extracellular and Protoplasm. The associated genes with CYTOCHALASIN B are SLC2A2 gene, PFDN5 gene, SLC2A1 gene, OMG gene and SPEN gene. The related lipids are Steroids, Lipopolysaccharides and Liposomes. The related experimental models are Xenograft Model.

Cross Reference

Introduction

To understand associated biological information of CYTOCHALASIN B, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with CYTOCHALASIN B?

CYTOCHALASIN B is suspected in Renal tubular disorder, Chagas Disease and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with CYTOCHALASIN B

MeSH term MeSH ID Detail
Thyroid Neoplasms D013964 33 associated lipids
Tongue Neoplasms D014062 15 associated lipids
Trisomy D014314 6 associated lipids
Tuberculosis D014376 20 associated lipids
Uremia D014511 33 associated lipids
Granulomatosis with Polyangiitis D014890 5 associated lipids
Wiskott-Aldrich Syndrome D014923 3 associated lipids
Wounds and Injuries D014947 20 associated lipids
Leukemia, Myelogenous, Chronic, BCR-ABL Positive D015464 17 associated lipids
Lymphoma, B-Cell D016393 24 associated lipids
Lymphoma, T-Cell D016399 11 associated lipids
Malaria, Falciparum D016778 22 associated lipids
Endometrial Neoplasms D016889 30 associated lipids
CREST Syndrome D017675 2 associated lipids
Glucose Intolerance D018149 13 associated lipids
Coronavirus Infections D018352 4 associated lipids
Systemic Inflammatory Response Syndrome D018746 4 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Micronuclei, Chromosome-Defective D048629 33 associated lipids
Per page 10 20 50 100 | Total 79

PubChem Associated disorders and diseases

What pathways are associated with CYTOCHALASIN B

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with CYTOCHALASIN B?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with CYTOCHALASIN B?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with CYTOCHALASIN B?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with CYTOCHALASIN B?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with CYTOCHALASIN B?

Xenograft Model

Xenograft Model are used in the study 'Endofacial competitive inhibition of the glucose transporter 1 activity by gossypol.' (Pérez A et al., 2009).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with CYTOCHALASIN B

Download all related citations
Per page 10 20 50 100 | Total 4982
Authors Title Published Journal PubMed Link
Nicosia SV and Tojo R Morphogenetic reaggregation and luteinization of mouse preantral follicle cells. 1979 Am. J. Anat. pmid:532792
Rhoten WB Emiocytosis of B granules from saurian pancreatic islets perifused in vitro. 1973 Am. J. Anat. pmid:4585905
Bondareff W and Tuttle RL Cortical cytoplasm and configurational changes of RGC-6 cells exposed to cytochalasin B. 1975 Am. J. Anat. pmid:1211367
Holtzer H et al. Effects of cytochalasin-B and colcimide on cells in muscle cultures. 1974 Am. J. Anat. pmid:4413125
Berkow RL and Dodson RW Functional analysis of the marginating pool of human polymorphonuclear leukocytes. 1987 Am. J. Hematol. pmid:3026170
Standley PR and Rose KA Insulin and insulin-like growth factor-1 modulation of glucose transport in arterial smooth muscle cells: implication of GLUT-4 in the vasculature. 1994 Am. J. Hypertens. pmid:8031552
Wann JG et al. Enhanced expression of glucose transporter 1 on erythrocyte membrane in hemodialysis patients: the possible role in erythrocyte ascorbate recycling. 2006 Am. J. Kidney Dis. pmid:16731301
Jacobs DB Fat cells: model system to investigate molecular mechanism(s) of sulfonylurea-potentiated glucose transport. 1985 Am. J. Med. pmid:3931463
Sato N et al. Hyposmolarity stimulates myeloperoxidase exocytosis from human polymorphonuclear leukocytes. 1990 Am. J. Med. Sci. pmid:2159710
Mooradian AD and Morin AM Brain uptake of glucose in diabetes mellitus: the role of glucose transporters. 1991 Am. J. Med. Sci. pmid:2000888
Liu S et al. Dynamic modulation of cytoskeleton during in vitro maturation in human oocytes. 2010 Am. J. Obstet. Gynecol. pmid:20579967
Kniss DA et al. Expression of functional insulin-like growth factor-I receptors by human amnion cells. 1993 Am. J. Obstet. Gynecol. pmid:8372873
O'Flaherty JT et al. Neutrophil-degranulating action of 5,12-dihydroxy-6,8,10,14-eicosatetraenoic acid and 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine. Comparison with other degranulating agents. 1981 Am. J. Pathol. pmid:6274199
Díaz-Ricart M et al. Inhibition of cytoskeletal assembly by cytochalasin B prevents signaling through tyrosine phosphorylation and secretion triggered by collagen but not by thrombin. 2002 Am. J. Pathol. pmid:11786426
Ward PA et al. Rat neutrophil activation and effects of lipoxygenase and cyclooxygenase inhibitors. 1984 Am. J. Pathol. pmid:6087668
White JG and Estensen RD Cytochemical electron microscopic studies of the action of phorbol myristate acetate on platelets. 1974 Am. J. Pathol. pmid:4814897
Ulevitch RJ et al. Hyperexpression of interferon-gamma-induced MHC class II genes associated with reorganization of the cytoskeleton. 1991 Am. J. Pathol. pmid:1907805
Lanni C and Becker EL Release of phospholipase A2 activity from rabbit peritoneal neutrophils by f-Met-Leu-Phe. 1983 Am. J. Pathol. pmid:6624881
O'Flaherty JT et al. Role of extracellular calcium and neutrophil degranulation responses to 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine. 1981 Am. J. Pathol. pmid:6271016
Ingram DA et al. Phagocytic activation of human neutrophils by the detergent component of fluosol. 1992 Am. J. Pathol. pmid:1316083